Inventor · disambiguated record
Minsheng He
Also filed as: HE MINSHENG
25 granted patents·12 pending applications·206 citations·filing 2005–2025
96Inventor score
Files withC4 THERAPEUTICS INC21TETRAPHASE PHARMACEUTICALS INC10BEGUIN CECILE2CHEN CHI-LI1CLARK ROGER B1
Top patents by PatentIndex Score
37 records- 0197US11407732B1Tricyclic degraders of Ikaros and AiolosC4 THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·10 cites·30 claims
- 0296US11524949B2Degraders and Degrons for targeted protein degradationC4 THERAPEUTICS INC·Filed 2020·Granted Dec 13, 2022·7 cites·18 claims
- 0396US10905768B1Heterocyclic degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2020·Granted Feb 2, 2021·31 cites·20 claims
- 0496US10849982B2C3-carbon linked glutarimide degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2018·Granted Dec 1, 2020·43 cites·17 claims
- 0596US10646575B2Heterocyclic degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2018·Granted May 12, 2020·32 cites·28 claims
- 0695US12048747B2Substituted piperidine Degronimers for Target Protein degradationC4 THERAPEUTICS INC·Filed 2020·Granted Jul 30, 2024·4 cites·22 claims
- 0794US11459335B2N/O-linked Degrons and Degronimers for protein degradationC4 THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·8 cites·23 claims
- 0893US11992531B2C3-carbon linked glutarimide degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2020·Granted May 28, 2024·3 cites·31 claims
- 0992US10072007B2Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2016·Granted Sep 11, 2018·6 cites·15 claims
- 1091US8828988B28-AZA tetracycline compoundsCLARK ROGER B·Filed 2012·Granted Sep 9, 2014·11 cites·14 claims
- 1189US12269807B2Crystalline forms of eravacyclineTETRAPHASE PHARMACEUTICALS INC·Filed 2023·Granted Apr 8, 2025·1 cites·17 claims
- 1288US8367654B28-AZA tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2010·Granted Feb 5, 2013·12 cites·13 claims
- 1387US12180225B2N/O-linked degrons and degronimers for protein degradationC4 THERAPEUTICS INC·Filed 2022·Granted Dec 31, 2024·1 cites·19 claims
- 1487US9315451B2Tetracycline compoundsCHEN CHI-LI·Filed 2010·Granted Apr 19, 2016·10 cites·15 claims
- 1586US11578044B2Crystalline forms of eravacyclineTETRAPHASE PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·2 cites·20 claims
- 1685US12076405B2Heterocyclic degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2021·Granted Sep 3, 2024·1 cites·20 claims
- 1785US10913712B2Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2019·Granted Feb 9, 2021·2 cites·4 claims
- 1884US10961190B2Crystalline forms of eravacyclineTETRAPHASE PHARMACEUTICALS INC·Filed 2017·Granted Mar 30, 2021·3 cites·12 claims
- 1984US10315992B2Tetracyline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2017·Granted Jun 11, 2019·4 cites·19 claims
- 2084US9573895B2Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2013·Granted Feb 21, 2017·8 cites·10 claims
- 2183US2025121069A1Heterocyclic degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2281US11753397B2Cereblon binders for the degradation of ikarosC4 THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·1 cites·19 claims
- 2381US9371283B2Polycyclic tetracycline compoundsXIAO XIAO-YI·Filed 2011·Granted Jun 21, 2016·6 cites·10 claims
- 2480US2025127903A1Substituted piperidine degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2576US12441740B2N/O-linked degrons and degronimers for protein degradationC4 THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·19 claims
- 2667US2023082430A1Tricyclic degraders of ikaros and aiolosC4 THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2766US2019077803A1Tetracycline compoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2862US2023190760A1Advantageous therapies for disorders mediated by ikaros or aiolosC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2962US2019076539A1Amine-linked c3-glutarimide degronimers for target protein degradationC4 THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3061US12454521B2Targeted protein degradationC4 THERAPEUTICS INC·Filed 2021·Granted Oct 28, 2025·0 cites·25 claims
- 3159US2024245677A1Selected compounds for targeted degradation of brd9C4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3255US2024391912A1Morphic forms of cft7455 and methods of manufacture thereofC4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3352US7629475B2Salvinorin derivatives and uses thereofMCLEAN HOSPITAL CORP·Filed 2005·Granted Dec 8, 2009·0 cites·13 claims
- 3450US2025289827A1Morphic forms of a mutant braf degrader and methods of manufacture thereofC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3549US2007213394A1Salvinorin derivatives and uses thereofBEGUIN CECILE·Filed 2006·Application pending·0 cites
- 3643US2017107179A1Polycyclic Tetracycline CompoundsTETRAPHASE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3736US2010324131A1Salvinorin Derivatives and Uses ThereofBEGUIN CECILE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Minsheng He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →